Maynard Um
-
-
-
-
-
-
-
Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
-
-
-
-
-
-
Incyte to present six oncology studies at ESMO Congress 2026
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $105 at Truist Securities
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Incyte (INCY)
-
-
-
-
-
-
-
Bernstein SocGen Group Starts Incyte (INCY) at Market Perform
-
-
-
-
-
-
-
Incyte (INCY) Tops Q1 EPS by 46c; offers guidance
-
466,296 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


